Momenta Pharmaceuticals, Inc. (MNTA)

[HattieTheWitch]

This has been discussed ad nauseam. The FTC would object vociferously to having one company own both branded Copaxone and the obligate technology for making a generic version of Copaxone for the US market.

Yes, that's why I stated "While the FTC would no doubt disallow TEVA from "cornering the market" on generic versions of enox (and Copaxone?)..."

So, although those hurdles would have to be overcome, there would be many more things about a buyout which would be beneficial to TEVA, IMHO.

Other than the trouble of handling the Copaxone (and m-enox) matters, there is substantial benefit to TEVA should they make such an acquisition.

Do you disagree?

Are there more things standing in TEVA's way than m-enox and generic Copaxone?